Siteone Therapeutics, Inc.

Biotechnology company · South San Francisco, California, United States

Siteone Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. It has received 10 US government small-business research awards (SBIR/STTR) from health agencies, $8.5 million in total, most recently in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Siteone Therapeutics at a glance

Typebiotechnology company

HeadquartersSouth San Francisco, California, United States

Employees (self-reported, 2021)8

What does Siteone Therapeutics do?

US government research funding

10 SBIR/STTR small-business research awards from US health agencies, $8.5 million in total (2013 to 2021). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Eye Institute, National Heart, Lung, and Blood Institute.

Frequently asked questions about Siteone Therapeutics

Where is Siteone Therapeutics headquartered?

Siteone Therapeutics, Inc. is headquartered in South San Francisco, California, United States.

What does Siteone Therapeutics do?

Siteone Therapeutics, Inc. is a biotechnology company.

Similar companies

Alector, Inc.South San Francisco, California, United States
Vaxart, Inc.South San Francisco, California, United States
Denali Therapeutics Inc.South San Francisco, California, United States
Aligos Therapeutics, Inc.South San Francisco, California, United States
PROFUSA, Inc.South San Francisco, California, United States
Quince Therapeutics, Inc.South San Francisco, California, United States
Allogene Therapeutics, Inc.South San Francisco, California, United States
Sutro Biopharma, Inc.South San Francisco, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences